Study of Vitamin D Deficiency in Hypothyroidism in a Tertiary Care Centre in Southern Bihar
- 1. PG Resident, Department of General Medicine, Narayan Medical College and Hospital, Sasaram, Bihar, India
- 2. Professor, Department of General Medicine, Narayan Medical College and Hospital, Sasaram, Bihar, India
- 3. Associate professor, Department of General Medicine, Narayan Medical College and Hospital, Sasaram, Bihar, India
Description
Aim: To Study vitamin D deficiency in hypothyroidism in a tertiary care centre in southern Bihar. Methods: This observational study was carried out over a period of 6 months in the Department of General Medicine, Narayan Medical College and Hospital, Sasaram, Bihar, India. This research comprised of 100 patients. They were classified as hypothyroid if their TSH level was greater than 5.0 mU/L and their T3 and T4 levels were lower than normal. Thyroid dysfunction patients’ serum T3, T4, and TSH levels with reference ranges (1.2 – 4.4 pg/ml for T3), (0.8 – 2.0 ng/dl for T4), and (0.5 – 5.0 mU/l for TSH). Results: The mean of all studied parameters, age and sex distribution in all studied groups. Overall mean age of the study population was 47.1 ± 7.29 years. Majority of the patients reported were female (60%). On comparing serum 25 (OH) vit. D levels according to the sex distribution, they were insignificantly decreased in females than those of male hypothyroid patients (t=-0.18, and t=-1.42, P >0.05) respectively. Conclusion: The patients with hypothyroidism suffered from hypovitaminosis D.
Abstract (English)
Aim: To Study vitamin D deficiency in hypothyroidism in a tertiary care centre in southern Bihar. Methods: This observational study was carried out over a period of 6 months in the Department of General Medicine, Narayan Medical College and Hospital, Sasaram, Bihar, India. This research comprised of 100 patients. They were classified as hypothyroid if their TSH level was greater than 5.0 mU/L and their T3 and T4 levels were lower than normal. Thyroid dysfunction patients’ serum T3, T4, and TSH levels with reference ranges (1.2 – 4.4 pg/ml for T3), (0.8 – 2.0 ng/dl for T4), and (0.5 – 5.0 mU/l for TSH). Results: The mean of all studied parameters, age and sex distribution in all studied groups. Overall mean age of the study population was 47.1 ± 7.29 years. Majority of the patients reported were female (60%). On comparing serum 25 (OH) vit. D levels according to the sex distribution, they were insignificantly decreased in females than those of male hypothyroid patients (t=-0.18, and t=-1.42, P >0.05) respectively. Conclusion: The patients with hypothyroidism suffered from hypovitaminosis D.
Files
IJPCR,Vol14,Issue9,Article26.pdf
Files
(301.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:22680e778b4c62331716662537b8814e
|
301.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-09-05
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue9,Article26.pdf
- Development Status
- Active
References
- 1. Makariou S., Liberopoulos E.N., Elisaf, M., Challa A. Novel roles of vitamin D in disease: What is new in 2011? Eur. J. Intern. Med. 2011; 22: 355–362. 2. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007; 357: 266–281. 3. Plum, L.A.; DeLuca, H.F. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 2010; 9: 941– 955. 4. Muscogiuri G., Tirabassi G., Bizzaro G., Orio F., Paschou S.A., Vryonidou A., Balercia G., Shoenfeld Y., Colao A. Vitamin D and thyroid disease: To D or not to D ? Eur. J. Clin. Nutr. 2015; 69: 291–296. 5. Kmie´c P. Sworczak, K. Vitamin D in thyroid disorders. Exp. Clin. Endocrinol. Diabetes 2015; 123: 386– 393. 6. Vondra K., Stárka L., Hampl R. Vitamin D and thyroid diseases. Physiol. Res. 2015; 64: S95–S100. 7. Bikle D. Nonclassic actions of vitamin D. J. Clin. Endocrinol. Metab. 2009: 94: 26–34. 8. Prietl B., Treiber G., Pieber T.R., Amrein K. Vitamin D and immune function. Nutrients 2013; 5:2502– 2521. 9. Wacker M., Holick M.F. Vitamin D— Effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013; 5: 111–148. 10. Holick M.F., Binkley N.C., BischoffFerrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011; 96: 1911– 1930 11. Kaplan MM. Clinical perspectives in the diagnosis of thyroid disease. Clin Chem. 1999; 45(8):1377-83. 12. Nicholas M, Robert H and Raynolds J, Spectroscopic Method for Quantitative Estimation of vitamin D, Ind Eng, Chem, Anal. ed.1941;13940: 227-31. 13. Sadat-Ali M, AlElq A, Al-Turki H, Al- Mulhim F and Al-Ali A. Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med. 2009; 29(5):378-82. 14. Weybrew J A, Matrone G and Baxley H M. Spectrophotometric. Anal. Chem. 1948; 20(8):759–62. 15. Vilarrasa N, Vendrell J, Maravall J, Elı0o I, Solano E and San Jose E. Isplasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010; 38(2): 235–42. 16. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press. 2010. 17. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008; 88: 582 -6. 18. Elizabeth A, Danielle Brulé, Cindy D, Krista A, Peter WF, Karl E Friedl et al. Dietary Reference Intakes for vitamin D: Justification for a review of the 1997 values. Am J Clin Nutr. 2009; 89 (3):719- 727. 19. Wolpowitz D and Gilchrest BA. The vitamin D questions: How much do you need and how should you get it? J Am AcadDermatol. 2006; 54(2):301– 17. 20. Elsammak MY, Al-Wossaibi AA, AlHoweish A and Alsaeed J. High prevalence of vitamin D deficiency in the sunny Eastern region of Saudi Arabia: a hospital-based study. East Mediterr Health J. 2011;17(4):317-22 21. Lippi G, Montagnana M, Meschi T, Borghi L. Vitamin D concentration and deficiency across different ages and genders. Aging Clin Exp Res. 2012; Feb 6. 22. Hashemipour S, Larijani B, Adibi H, Ebrahim J, Mojtaba S and Mohammad P. Vitamin D deficiency and causative factors in the population of Tehran. BMC. 2004; 4:38. 23. Sedrani SH. Low 25-hydroxyvitamin D and normal concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab. 1984; 28(3):181-85. 24. Al-Jurayyan NA, El-Desouki ME, AlHerbish AS, Al-Mazyad AS and AlQhtani MM. Nutritional rickets and osteomalacia in school children and adolescent. Saudi Med J. 2002; 23: 182–85. 25. Fida NM. Assessment of nutritional rickets in Western Saudi Arabia. Saudi Med J. 2003; 24:337–40. 26. Naeem Z, Abdul Rahman Al Mohaimeed, Khalil FS, Ismail, Faiza Sh and Inam SN. Vitamin D status among population of Qassim Region, Saudi Arabia. International Journal of Health Sciences, Qassim University. 2011; (5)2. 27. Kobayashi T, Okano T, Shida 5, Okada K, Suginohara T, Nakao H, Kuroda E et al. Variation of 25- hydroxyvitamin D3 and 25- hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects. J Nutr Sci Vitaminol (Tokyo). 1983; 29: 271-81. 28. Benucci A, Tommasi M, Fantappie B, Scardigli 5, Ottanelli 5, Pratesi E and Romano. Serum 25- hydroxyvitamin D levels in normal subjects: seasonal variations and relationships with parathyroid hormone and osteocalcin. J Nucl Biol Med. 1993; 37: 77-82. 29. Sedrani SH, Elidrissy AW, El Arabi KM. Sunlight and vitamin D status in normal Saudi subjects. Am J Clin Nutr. 1983; 38(1):129-32. 30. Yamashita H, Noguchi S and Takatsu K. High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J .2001; 48: 63–69. 31. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–81. 32. Kivity S, Agmon-Levin N and Zisappl M et al., Vitamin D and autoimmune thyroid diseases, Cellular and Molecular Immunology. 2011; (8)3: 43 –47. 33. Byron Richards. Low Vitamin D Contributes to Thyroid Problems. Health news 2008. 34. Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, Miyatsuka T. et al. Serum vitamin D levels are decreasedand associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine. 2012 May 1. [Epub ahead of print] 35. Baeke F, Takiishi T, Korf H, Gysemans C and Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 2010; 10(4):482–96. 36. Ponsonby A L, Pezic A, Ellis J, Morley R, Cameron F and Carlin. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a metaregression analysis. Am. J. Epidemiol.2008; 168(4):358–65. 37. Naderi N, Farnood A, Habibi M, Derakhshan F, Balaii H, Motahari Z, Agah M R et al. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J. Gastroenterol. Hepatol. 2008; 23(12): 1816–22. 38. Zhou H, Xu C and Gu M. Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis. Clin Endocrinol (Oxf). 2009; 70(6): 938–45. 39. Rotondi M and Chiovato L. The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-c inducible chemokines and their receptor. Curr. Pharm. Des.2011; 17(29):3202–16. 40. Effraimidis G, Badenhoop K, Tijssen JG and Wiersinga WM. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol. 2012 Jul; 167(1):43-8. 41. Al-Hakeim HK. Serum Levels of Lipids, Calcium and Magnesium in Women with Hypothyroidism and Cardiovascular Diseases. J Lab Physicians. 2009; 1(2): 49–52. 42. Kafaji M. S. A. A.-., & Alsaadi Z. H. Pinworms Infection: Review. Journal of Medical Research and Health Sciences, 2022; 5(8): 2182–2189.